Role of NLRP3 signals in ischemia/reperfusion-induced organ injury

NLRP3信号在缺血/再灌注引起的器官损伤中的作用

基本信息

  • 批准号:
    10844207
  • 负责人:
  • 金额:
    $ 90.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary: This proposal evaluates how intracellular signaling pathways generated by the cytoplasmic innate immune receptor NLRP3 are regulated in renal tubular epithelial cells. Renal tubule epithelial cells play a central role in ischemic kidney injury, and our lab and others have shown that global NLRP3 blockade can prevent experimental renal ischemia/reperfusion injury. NLRP3 signaling classically results in cell death (pyroptosis), however alternative NLRP3 signaling pathways have recently been identified that lead to secretion of IL1b/IL18 without cell death. Thus, selectively targeting NLRP3-mediated cell death signaling might prevent renal tubule injury while still preserving the host’s ability to secrete IL1b/IL18 and mount needed host defense responses (e.g., antimicrobial responses). The project is highly significant for the development of targeted therapeutics for ischemic kidney injury, which occurs frequently in hospitalized patients and in all organs procured for transplantation. Broad/long-term objectives: The long-term goals of the proposed research are to define how NLRP3 contributes to injurious tissue responses in the kidney and how its signaling can be effectively and selectively targeted. Specific Aims: The specific objective of this proposal is to test the hypothesis that the cytoplasmic pattern recognition receptor NLRP3 can be specifically targeted in renal tubular epithelial cells to selectively block NLRP3-mediated renal tubule cell death, while preserving IL1b/IL18 responses. Aim 1 defines the mechanisms that drive NLRP3 signaling pathways in proximal renal tubule cells. Aim 2 determines how NLRP3 signaling can be selectively targeted in the proximal renal tubule cells. Aim 3 determines how NLRP3 signaling, and its selective blockade, influences renal tubular injury/IL1b/IL18 secretion in vivo, when NLRP3 expression is isolated to the renal tubule epithelium. Research Design and Methods for Achieving the Stated Goals: Aim 1 compares and contrasts activation of NLRP3 in human and murine proximal renal tubular cells and will determine how NLRP3 activation contributes to pyroptosis and/or production of IL1b/IL18. Aim 2 will determine how specific NLRP3 activation pathways can be targeted in the two species to prevent cell death and preserve cytokine secretion. Aim 3 will focus on understanding how NLRP3 restricted to the renal tubule epithelium in vivo can be targeted to prevent renal tubular injury without impairing IL1b/IL18. In the third aim, two different models of NLRP3 expression will be used; one where the renal tubules express a conditional loss-of-function of NLRP3 and another where there is a hyper-activatable form of NLRP3. The studies here will determine whether canonical NLRP3-mediated cell death signaling can be uncoupled from noncanonical signaling to prevent cell death while preserving secretion of IL1b/IL18. Health Relatedness of Project: If the aims of this proposal are met, we will learn how activation of NLRP3 (deemed a central cellular stress detector) can be regulated to target a common disease, renal ischemia/reperfusion injury. This knowledge is crucial for the development of rational targeted therapies for prevention or amelioration of renal ischemia/reperfusion injury in clinical situations where hypoxia is anticipated.
项目概述:该提案评估了细胞质固有的细胞内信号通路如何产生, 免疫受体NLRP 3在肾小管上皮细胞中受到调节。肾小管上皮细胞在肾脏疾病中起着重要作用。 缺血性肾损伤,我们的实验室和其他实验室已经表明,整体NLRP 3阻断可以防止实验性肾损伤, 缺血/再灌注损伤。NLRP 3信号传导经典地导致细胞死亡(焦亡),然而替代性NLRP 3 最近已经鉴定了导致IL 1b/IL 18分泌而没有细胞死亡的信号传导途径。因此,选择性地 靶向NLRP 3介导的细胞死亡信号可能会防止肾小管损伤,同时仍然保留宿主的能力, 分泌IL 1b/IL 18并产生所需的宿主防御反应(例如,抗微生物反应)。该项目高度 对于缺血性肾损伤的靶向治疗的发展具有重要意义,缺血性肾损伤在住院患者中经常发生。 患者和所有用于移植的器官。 广泛/长期目标:拟议研究的长期目标是确定NLRP 3如何有助于 肾脏中的损伤组织反应以及如何有效和选择性地靶向其信号传导。 具体目的:本提案的具体目的是检验细胞质模式识别 受体NLRP 3可以特异性靶向肾小管上皮细胞,以选择性地阻断NLRP 3介导的肾 肾小管细胞死亡,同时保留IL 1b/IL 18应答。目的1定义了驱动NLRP 3信号传导的机制 近端肾小管细胞中的通路。目的2确定NLRP 3信号传导如何可以选择性地靶向于细胞中。 近端肾小管细胞目的3确定NLRP 3信号传导及其选择性阻断如何影响肾脏 肾小管损伤/体内IL 1b/IL 18分泌,当NLRP 3表达被分离到肾小管上皮时。 研究设计和实现既定目标的方法:目标1比较和对比NLRP 3的激活 在人类和小鼠近端肾小管细胞中,并将确定NLRP 3激活如何促进细胞凋亡 和/或IL 1b/IL 18的产生。目的2将确定如何在细胞中靶向特定的NLRP 3激活途径。 这两个物种,以防止细胞死亡和保护细胞因子分泌。目标3将侧重于了解NLRP 3 在体内仅限于肾小管上皮细胞,可靶向预防肾小管损伤而不损害IL 1b/IL 18。 在第三个目标中,将使用两种不同的NLRP 3表达模型;一种是肾小管表达条件性的NLRP 3。 NLRP 3的功能丧失和另一种存在NLRP 3的超活化形式。这里的研究将决定 经典NLRP 3介导的细胞死亡信号是否可以与非经典信号解偶联以防止细胞死亡。 死亡,同时保持IL 1b/IL 18的分泌。 项目的健康相关性:如果本提案的目标得到满足,我们将了解NLRP 3(被认为是一种 中枢细胞应激检测器)可以被调节以靶向常见疾病,肾缺血/再灌注损伤。这 知识对于开发合理的靶向治疗以预防或改善肾损害至关重要。 在预期缺氧的临床情况下的缺血/再灌注损伤。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dianne B Mckay其他文献

Dianne B Mckay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dianne B Mckay', 18)}}的其他基金

Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10555070
  • 财政年份:
    2021
  • 资助金额:
    $ 90.5万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10659033
  • 财政年份:
    2021
  • 资助金额:
    $ 90.5万
  • 项目类别:
JAML-CAR regulation of adipose tissue homeostasis
JAML-CAR对脂肪组织稳态的调节
  • 批准号:
    10348218
  • 财政年份:
    2021
  • 资助金额:
    $ 90.5万
  • 项目类别:
JAML-CAR regulation of adipose tissue homeostasis
JAML-CAR对脂肪组织稳态的调节
  • 批准号:
    10217488
  • 财政年份:
    2021
  • 资助金额:
    $ 90.5万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10494248
  • 财政年份:
    2021
  • 资助金额:
    $ 90.5万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10375997
  • 财政年份:
    2021
  • 资助金额:
    $ 90.5万
  • 项目类别:
AIM2 as a negative regulator of renal ischemia/reperfusion injury
AIM2 作为肾缺血/再灌注损伤的负调节因子
  • 批准号:
    10043487
  • 财政年份:
    2020
  • 资助金额:
    $ 90.5万
  • 项目类别:
AIM2 as a negative regulator of renal ischemia/reperfusion injury
AIM2 作为肾缺血/再灌注损伤的负调节因子
  • 批准号:
    10170263
  • 财政年份:
    2020
  • 资助金额:
    $ 90.5万
  • 项目类别:
Role of NOD2 in ischemia reperfusion injury
NOD2在缺血再灌注损伤中的作用
  • 批准号:
    9750718
  • 财政年份:
    2017
  • 资助金额:
    $ 90.5万
  • 项目类别:
Role of NOD2 in ischemia reperfusion injury
NOD2在缺血再灌注损伤中的作用
  • 批准号:
    9290040
  • 财政年份:
    2017
  • 资助金额:
    $ 90.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 90.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了